| Medical Guidelines |
Reason for Update |
| BRAF Genetic Testing In Patients With Melanoma AHS - M2029 |
Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed. |
| Detection of Circulating Tumor Cells and Cell Free DNA in Cancer Management AHS - G2054 |
Deleted coding table from Billing/Coding section. Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed. Minor reformatting of policy statements; no change to policy statement intent. |
| Gene Expression Profiling for Uveal Melanoma AHS - M2071 |
Statement added to the When Not Covered section that testing is investigational in all other situations. |
| General Genetic Testing, Germline Disorders AHS - M2145 |
Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed |
| General Genetic Testing, Somatic Disorders AHS - M2146 |
Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed. |
| Molecular Panel Testing of Cancers to Identify Targeted Therapy AHS - M2109 |
Wording in the Policy, When Covered, and/or Not Covered section(s) changed from Medical Necessity to Reimbursement language, where needed. |
| Mutation Analysis in Myeloproliferative Neoplasms AHS - M2101 |
Wording in the Policy, When Covered, and/or Not Covered section(s) changed from MedicalNecessity to Reimbursement language, where needed |
Blue Connect